Tyra Biosciences annual r&d spending
2020
2021
2022
2023
2024
2025
Tyra Biosciences R&D Spending Growth & History (TYRA)
Tyra Biosciences's r&d spending was $102.9M for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $102.9M | $22.9M | +28.54% |
| 2024 | 2024-12-31 | $80.1M | $17.6M | +28.09% |
| 2023 | 2023-12-31 | $62.5M | $19.5M | +45.36% |
| 2022 | 2022-12-31 | $43.0M | $22.4M | +108.41% |
| 2021 | 2021-12-31 | $20.6M | $13.4M | +186.49% |
| 2020 | 2020-12-31 | $7.2M | — | — |
Tyra Biosciences quarterly r&d spending
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $39.2M | $14.9M | +61.24% |
| Q1 2026 | 2026-03-31 | $33.5M | $8.5M | +34.07% |
| Q4 2025 | 2025-12-31 | $28.2M | $6.0M | +27.08% |
| Q3 2025 | 2025-09-30 | $25.5M | $2.8M | +12.21% |
| Q2 2025 | 2025-06-30 | $24.3M | $6.3M | +35.07% |
| Q1 2025 | 2025-03-31 | $25.0M | $7.8M | +45.11% |
| Q4 2024 | 2024-12-31 | $22.2M | $1.5M | +7.27% |
| Q3 2024 | 2024-09-30 | $22.7M | $3.4M | +17.78% |
| Q2 2024 | 2024-06-30 | $18.0M | $5.8M | +47.98% |
| Q1 2024 | 2024-03-31 | $17.2M | $6.8M | +65.29% |
| Q4 2023 | 2023-12-31 | $20.7M | $10.3M | +98.80% |
| Q3 2023 | 2023-09-30 | $19.3M | $8.4M | +76.56% |
| Q2 2023 | 2023-06-30 | $12.2M | $115,000 | +0.95% |
| Q1 2023 | 2023-03-31 | $10.4M | $763,000 | +7.91% |
| Q4 2022 | 2022-12-31 | $10.4M | $3.2M | +43.48% |
| Q3 2022 | 2022-09-30 | $10.9M | $5.4M | +99.03% |
| Q2 2022 | 2022-06-30 | $12.0M | $7.7M | +174.98% |
| Q1 2022 | 2022-03-31 | $9.6M | $6.1M | +173.85% |
| Q4 2021 | 2021-12-31 | $7.2M | — | — |
| Q3 2021 | 2021-09-30 | $5.5M | $3.6M | +194.52% |
| Q2 2021 | 2021-06-30 | $4.4M | — | — |
| Q1 2021 | 2021-03-31 | $3.5M | — | — |
| Q3 2020 | 2020-09-30 | $1.9M | — | — |
Tyra Biosciences r&d spending trends
Over the last five fiscal years, Tyra Biosciences's r&d spending increased from $7.2M to $102.9M, a change of $95.7M. The latest reported quarter, Q2 2026, shows $39.2M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗